SEC Tracker
Get the app

Sionna Therapeutics SION

OrbiMed Private Investments VIII (Shareholder) plans to sell 1,047,770 SION shares, about $46.5M

Form
144
Filed
Importance
Routine
  1. Approximate sale date: Nov 24, 2025
  2. Broker: TD Cowen
  3. Shares acquired by: IPO
  4. 10b5-1 plan adopted: Feb 10, 2025

All of OrbiMed Private Investments VIII's insider filings, holdings and planned sales

Form 4s that likely executed this notice (SEC Tracker's match by person, company, dates and shares):

  • Sold 94,583 shares at $44.54 on Nov 24, 2025 · Form 4
  • Sold 11,890 shares at $44.6 on Nov 25, 2025 · Form 4
  • Sold 1,600 shares at $44.49 on Nov 26, 2025 · Form 4
  • Sold 900 shares at $44.5 on Dec 17, 2025 · Form 4
  • Sold 100 shares at $44.49 on Dec 18, 2025 · Form 4
  • Sold 875 shares at $44.49 on Dec 19, 2025 · Form 4
  • Sold 33,356 shares at $44.55 on Dec 24, 2025 · Form 4
  • Sold 1,890 shares at $44.57 on Feb 2, 2026 · Form 4
  • Sold 29,063 shares at $44.58 on Feb 3, 2026 · Form 4

Written from the Form 144 on EDGAR. Check the filing before you rely on it.

Open in the appGet the appView on EDGAR

Get an email when Sionna Therapeutics files

Only major filings: results, leadership changes, listing notices and other major events, each with the plain-English summary when we have one or the key facts and the EDGAR link. Routine insider filings never email. Confirm once; unsubscribe in one click.

Similar companies

Companies of similar size in SIC 2834 and related industry codes: the same peer list as the financial tables.

  1. Emergent BioSolutions EBS public float $343M, Jun 30, 2025
  2. Northwest Biotherapeutics NWBO public float $340M, Jun 30, 2025
  3. Amarin AMRN public float $335M, Jun 30, 2025
  4. Rigel Pharmaceuticals RIGL public float $332M, Jun 30, 2025
  5. Usana Health Sciences USNA public float $328M, Jun 27, 2025